Glioblastoma Multiforme clinical trials

Explore recruiting glioblastoma multiforme clinical trials.

Recruiting glioblastoma multiforme studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glioblastoma Multiforme trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, double-blind, placebo-controlled, randomized, proof-of-concept study evaluating LSTA1 when added to standard of care (temozolomide) versus temozolomide and matching LSTA1 placebo in subjects with newly diagnosed Glioblastoma Multiforme (GBM)

Estonia, Latvia, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

Phase 0 lead-in trial of Pitavastatin in primary and recurrent Glioblastoma patients

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients

Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous system

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Glioblastoma Multiforme trials by city

Glioblastoma Multiforme in Toronto Glioblastoma Multiforme in Vancouver Glioblastoma Multiforme in Montreal Glioblastoma Multiforme in Calgary Glioblastoma Multiforme in Edmonton Glioblastoma Multiforme in Ottawa Glioblastoma Multiforme in Winnipeg Glioblastoma Multiforme in Quebec City Glioblastoma Multiforme in Hamilton Glioblastoma Multiforme in Kitchener Glioblastoma Multiforme in London Glioblastoma Multiforme in Halifax Glioblastoma Multiforme in New York Glioblastoma Multiforme in Los Angeles Glioblastoma Multiforme in Chicago Glioblastoma Multiforme in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease